title: Uridine affects liver protein glycosylation, insulin signaling, and heme biosynthesis.
abstract: Purines and pyrimidines are complementary bases of the genetic code. The roles of purines and their derivatives in cellular signal transduction and energy metabolism are well-known. In contrast, the roles of pyrimidines and their derivatives in cellular function remain poorly understood. In this study, the roles of uridine, a pyrimidine nucleoside, in liver metabolism are examined in mice. We report that short-term uridine administration in C57BL/6J mice increases liver protein glycosylation profiles, reduces phosphorylation level of insulin signaling proteins, and activates the HRI-eIF-2α-ATF4 heme-deficiency stress response pathway. Short-term uridine administration is also associated with reduced liver hemin level and reduced ability for insulin-stimulated blood glucose removal during an insulin tolerance test. Some of the short-term effects of exogenous uridine in C57BL/6J mice are conserved in transgenic UPase1-/- mice with long-term elevation of endogenous uridine level. UPase1-/- mice exhibit activation of the liver HRI-eIF-2α-ATF4 heme-deficiency stress response pathway. UPase1-/- mice also exhibit impaired ability for insulin-stimulated blood glucose removal. However, other short-term effects of exogenous uridine in C57BL/6J mice are not conserved in UPase1-/- mice. UPase1-/- mice exhibit normal phosphorylation level of liver insulin signaling proteins and increased liver hemin concentration compared to untreated control C57BL/6J mice. Contrasting short-term and long-term consequences of uridine on liver metabolism suggest that uridine exerts transient effects and elicits adaptive responses. Taken together, our data support potential roles of pyrimidines and their derivatives in the regulation of liver metabolism.
authors.affiliation: Nevada Cancer Institute, Las Vegas, Nevada, United States of America; Desert Research Institute, Las Vegas, Nevada, United States of America.
authors.forename: Yasuyo
authors.initials: Y
authors.lastname: Urasaki
authors.affiliation: Nevada Cancer Institute, Las Vegas, Nevada, United States of America; Desert Research Institute, Las Vegas, Nevada, United States of America.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Pizzorno
authors.affiliation: Nevada Cancer Institute, Las Vegas, Nevada, United States of America; Desert Research Institute, Las Vegas, Nevada, United States of America.
authors.forename: Thuc T
authors.initials: TT
authors.lastname: Le
mesh_terms: D051701:Activating Transcription Factor 4 / Q000378:metabolism; D000818:Animals; D001786:Blood Glucose / Q000187:drug effects; D015852:Eukaryotic Initiation Factor-2 / Q000378:metabolism; D005947:Glucose / Q000378:metabolism; D006031:Glycosylation / Q000187:drug effects*; D006418:Heme / Q000378:metabolism*; D007328:Insulin / Q000378:metabolism*; D008099:Liver / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D010766:Phosphorylation / Q000187:drug effects; D014176:Protein Biosynthesis / Q000187:drug effects*; D015398:Signal Transduction / Q000187:drug effects*; D014529:Uridine / Q000008:administration & dosage*
chemical_list: C081452:Atf4 protein, mouse; D001786:Blood Glucose; D015852:Eukaryotic Initiation Factor-2; D007328:Insulin; D051701:Activating Transcription Factor 4; D006418:Heme; D005947:Glucose; D014529:Uridine